SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-029487
Filing Date
2022-11-10
Accepted
2022-11-10 16:14:10
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q blcm-20220930.htm   iXBRL 10-Q 1395340
2 EX-31.1 a2022q3exhibit311.htm EX-31.1 11805
3 EX-32.1 a2022q3exhibit321.htm EX-32.1 6018
  Complete submission text file 0001628280-22-029487.txt   5387884

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20220930.xsd EX-101.SCH 37259
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20220930_cal.xml EX-101.CAL 46343
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20220930_def.xml EX-101.DEF 183699
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20220930_lab.xml EX-101.LAB 436308
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20220930_pre.xml EX-101.PRE 287348
45 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20220930_htm.xml XML 800389
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 221377341
SIC: 2834 Pharmaceutical Preparations